nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Vandetanib—thyroid cancer	0.039	0.508	CbGbCtD
Tiagabine—CYP3A4—Sorafenib—thyroid cancer	0.0235	0.306	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—thyroid cancer	0.0143	0.186	CbGbCtD
Tiagabine—Decreased appetite—Sorafenib—thyroid cancer	0.00121	0.00131	CcSEcCtD
Tiagabine—Thrombophlebitis—Epirubicin—thyroid cancer	0.00121	0.00131	CcSEcCtD
Tiagabine—Ecchymosis—Doxorubicin—thyroid cancer	0.00121	0.00131	CcSEcCtD
Tiagabine—Mouth ulceration—Doxorubicin—thyroid cancer	0.00121	0.00131	CcSEcCtD
Tiagabine—Neoplasm—Doxorubicin—thyroid cancer	0.00121	0.00131	CcSEcCtD
Tiagabine—Bladder pain—Doxorubicin—thyroid cancer	0.00121	0.00131	CcSEcCtD
Tiagabine—Fatigue—Sorafenib—thyroid cancer	0.0012	0.0013	CcSEcCtD
Tiagabine—Pain—Sorafenib—thyroid cancer	0.00119	0.00129	CcSEcCtD
Tiagabine—Constipation—Sorafenib—thyroid cancer	0.00119	0.00129	CcSEcCtD
Tiagabine—Hypertonia—Doxorubicin—thyroid cancer	0.00117	0.00127	CcSEcCtD
Tiagabine—Eczema—Epirubicin—thyroid cancer	0.00116	0.00126	CcSEcCtD
Tiagabine—Abnormal vision—Doxorubicin—thyroid cancer	0.00116	0.00126	CcSEcCtD
Tiagabine—Eye pain—Epirubicin—thyroid cancer	0.00116	0.00125	CcSEcCtD
Tiagabine—Sepsis—Doxorubicin—thyroid cancer	0.00116	0.00125	CcSEcCtD
Tiagabine—Mental disability—Doxorubicin—thyroid cancer	0.00116	0.00125	CcSEcCtD
Tiagabine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00114	0.00123	CcSEcCtD
Tiagabine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00113	0.00123	CcSEcCtD
Tiagabine—Phlebitis—Doxorubicin—thyroid cancer	0.00112	0.00122	CcSEcCtD
Tiagabine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00112	0.00121	CcSEcCtD
Tiagabine—Increased appetite—Epirubicin—thyroid cancer	0.00111	0.00121	CcSEcCtD
Tiagabine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00111	0.0012	CcSEcCtD
Tiagabine—Urticaria—Sorafenib—thyroid cancer	0.0011	0.0012	CcSEcCtD
Tiagabine—Body temperature increased—Sorafenib—thyroid cancer	0.0011	0.00119	CcSEcCtD
Tiagabine—Abdominal pain—Sorafenib—thyroid cancer	0.0011	0.00119	CcSEcCtD
Tiagabine—Dermatitis bullous—Epirubicin—thyroid cancer	0.00109	0.00119	CcSEcCtD
Tiagabine—Eczema—Doxorubicin—thyroid cancer	0.00108	0.00117	CcSEcCtD
Tiagabine—Eye pain—Doxorubicin—thyroid cancer	0.00107	0.00116	CcSEcCtD
Tiagabine—Hypoglycaemia—Epirubicin—thyroid cancer	0.00107	0.00116	CcSEcCtD
Tiagabine—Hyponatraemia—Epirubicin—thyroid cancer	0.00105	0.00114	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00105	0.00113	CcSEcCtD
Tiagabine—Osteoarthritis—Epirubicin—thyroid cancer	0.00105	0.00113	CcSEcCtD
Tiagabine—Diplopia—Epirubicin—thyroid cancer	0.00105	0.00113	CcSEcCtD
Tiagabine—Increased appetite—Doxorubicin—thyroid cancer	0.00103	0.00112	CcSEcCtD
Tiagabine—Affect lability—Epirubicin—thyroid cancer	0.00103	0.00111	CcSEcCtD
Tiagabine—Migraine—Epirubicin—thyroid cancer	0.00103	0.00111	CcSEcCtD
Tiagabine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00103	0.00111	CcSEcCtD
Tiagabine—Hypersensitivity—Sorafenib—thyroid cancer	0.00102	0.00111	CcSEcCtD
Tiagabine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00101	0.0011	CcSEcCtD
Tiagabine—Face oedema—Epirubicin—thyroid cancer	0.00101	0.00109	CcSEcCtD
Tiagabine—Asthenia—Sorafenib—thyroid cancer	0.000998	0.00108	CcSEcCtD
Tiagabine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000992	0.00107	CcSEcCtD
Tiagabine—Mood swings—Epirubicin—thyroid cancer	0.000991	0.00107	CcSEcCtD
Tiagabine—Pruritus—Sorafenib—thyroid cancer	0.000984	0.00107	CcSEcCtD
Tiagabine—Ataxia—Epirubicin—thyroid cancer	0.000983	0.00107	CcSEcCtD
Tiagabine—Dehydration—Epirubicin—thyroid cancer	0.000973	0.00105	CcSEcCtD
Tiagabine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000972	0.00105	CcSEcCtD
Tiagabine—Diplopia—Doxorubicin—thyroid cancer	0.000968	0.00105	CcSEcCtD
Tiagabine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000968	0.00105	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000968	0.00105	CcSEcCtD
Tiagabine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000966	0.00105	CcSEcCtD
Tiagabine—Dry skin—Epirubicin—thyroid cancer	0.000959	0.00104	CcSEcCtD
Tiagabine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000955	0.00103	CcSEcCtD
Tiagabine—Migraine—Doxorubicin—thyroid cancer	0.000952	0.00103	CcSEcCtD
Tiagabine—Affect lability—Doxorubicin—thyroid cancer	0.000952	0.00103	CcSEcCtD
Tiagabine—Hypokalaemia—Epirubicin—thyroid cancer	0.000952	0.00103	CcSEcCtD
Tiagabine—Diarrhoea—Sorafenib—thyroid cancer	0.000952	0.00103	CcSEcCtD
Tiagabine—Face oedema—Doxorubicin—thyroid cancer	0.000934	0.00101	CcSEcCtD
Tiagabine—Gastritis—Epirubicin—thyroid cancer	0.000926	0.001	CcSEcCtD
Tiagabine—Muscular weakness—Epirubicin—thyroid cancer	0.000922	0.000999	CcSEcCtD
Tiagabine—Dizziness—Sorafenib—thyroid cancer	0.00092	0.000996	CcSEcCtD
Tiagabine—Mood swings—Doxorubicin—thyroid cancer	0.000917	0.000993	CcSEcCtD
Tiagabine—Ataxia—Doxorubicin—thyroid cancer	0.00091	0.000986	CcSEcCtD
Tiagabine—Asthma—Epirubicin—thyroid cancer	0.000904	0.000979	CcSEcCtD
Tiagabine—Dysphagia—Epirubicin—thyroid cancer	0.000904	0.000979	CcSEcCtD
Tiagabine—Influenza—Epirubicin—thyroid cancer	0.000904	0.000979	CcSEcCtD
Tiagabine—Dehydration—Doxorubicin—thyroid cancer	0.0009	0.000975	CcSEcCtD
Tiagabine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000893	0.000968	CcSEcCtD
Tiagabine—Dry skin—Doxorubicin—thyroid cancer	0.000887	0.000961	CcSEcCtD
Tiagabine—Vomiting—Sorafenib—thyroid cancer	0.000884	0.000958	CcSEcCtD
Tiagabine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000884	0.000957	CcSEcCtD
Tiagabine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000881	0.000954	CcSEcCtD
Tiagabine—Angina pectoris—Epirubicin—thyroid cancer	0.00088	0.000954	CcSEcCtD
Tiagabine—Rash—Sorafenib—thyroid cancer	0.000877	0.00095	CcSEcCtD
Tiagabine—Dermatitis—Sorafenib—thyroid cancer	0.000876	0.000949	CcSEcCtD
Tiagabine—Headache—Sorafenib—thyroid cancer	0.000871	0.000944	CcSEcCtD
Tiagabine—Bronchitis—Epirubicin—thyroid cancer	0.000869	0.000942	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—thyroid cancer	0.000856	0.000928	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—thyroid cancer	0.000853	0.000924	CcSEcCtD
Tiagabine—Dysuria—Epirubicin—thyroid cancer	0.000845	0.000915	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—thyroid cancer	0.000836	0.000906	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—thyroid cancer	0.000836	0.000906	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—thyroid cancer	0.000836	0.000906	CcSEcCtD
Tiagabine—Pollakiuria—Epirubicin—thyroid cancer	0.000835	0.000904	CcSEcCtD
Tiagabine—Nausea—Sorafenib—thyroid cancer	0.000826	0.000895	CcSEcCtD
Tiagabine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000825	0.000894	CcSEcCtD
Tiagabine—Weight increased—Epirubicin—thyroid cancer	0.000823	0.000891	CcSEcCtD
Tiagabine—Weight decreased—Epirubicin—thyroid cancer	0.000818	0.000886	CcSEcCtD
Tiagabine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000815	0.000883	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—thyroid cancer	0.000815	0.000882	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—thyroid cancer	0.000811	0.000878	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—thyroid cancer	0.000804	0.000871	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—thyroid cancer	0.000792	0.000858	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00079	0.000856	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—thyroid cancer	0.000786	0.000851	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—thyroid cancer	0.000783	0.000848	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—thyroid cancer	0.000783	0.000848	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—thyroid cancer	0.000782	0.000847	CcSEcCtD
Tiagabine—Sweating—Epirubicin—thyroid cancer	0.000773	0.000837	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—thyroid cancer	0.000773	0.000837	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—thyroid cancer	0.000768	0.000832	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000763	0.000827	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—thyroid cancer	0.000761	0.000824	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—thyroid cancer	0.00076	0.000823	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—thyroid cancer	0.000757	0.00082	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—thyroid cancer	0.000756	0.000819	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000754	0.000817	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—thyroid cancer	0.00075	0.000812	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—thyroid cancer	0.000733	0.000794	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000731	0.000792	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—thyroid cancer	0.000727	0.000788	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—thyroid cancer	0.000727	0.000787	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—thyroid cancer	0.000725	0.000786	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000725	0.000785	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000725	0.000785	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—thyroid cancer	0.000723	0.000784	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00072	0.00078	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—thyroid cancer	0.000718	0.000778	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—thyroid cancer	0.000715	0.000774	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—thyroid cancer	0.000713	0.000772	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—thyroid cancer	0.000711	0.00077	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—thyroid cancer	0.000703	0.000762	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—thyroid cancer	0.0007	0.000758	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—thyroid cancer	0.000697	0.000755	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—thyroid cancer	0.000675	0.000731	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—thyroid cancer	0.000673	0.000729	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—thyroid cancer	0.000671	0.000727	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—thyroid cancer	0.000669	0.000725	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000666	0.000721	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—thyroid cancer	0.000664	0.00072	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000659	0.000714	CcSEcCtD
Tiagabine—Chills—Epirubicin—thyroid cancer	0.000649	0.000703	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—thyroid cancer	0.000645	0.000699	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—thyroid cancer	0.000639	0.000692	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—thyroid cancer	0.000624	0.000676	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—thyroid cancer	0.000621	0.000672	CcSEcCtD
Tiagabine—Tension—Epirubicin—thyroid cancer	0.000618	0.000669	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—thyroid cancer	0.000617	0.000668	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—thyroid cancer	0.000612	0.000663	CcSEcCtD
Tiagabine—Back pain—Epirubicin—thyroid cancer	0.000609	0.00066	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—thyroid cancer	0.000606	0.000656	CcSEcCtD
Tiagabine—Chills—Doxorubicin—thyroid cancer	0.000601	0.000651	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—thyroid cancer	0.000592	0.000641	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000584	0.000633	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—thyroid cancer	0.000582	0.00063	CcSEcCtD
Tiagabine—Agitation—Epirubicin—thyroid cancer	0.000579	0.000627	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—thyroid cancer	0.000574	0.000622	CcSEcCtD
Tiagabine—Tension—Doxorubicin—thyroid cancer	0.000572	0.000619	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—thyroid cancer	0.000571	0.000618	CcSEcCtD
Tiagabine—Malaise—Epirubicin—thyroid cancer	0.000568	0.000615	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—thyroid cancer	0.000566	0.000613	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—thyroid cancer	0.000566	0.000613	CcSEcCtD
Tiagabine—Syncope—Epirubicin—thyroid cancer	0.000565	0.000612	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—thyroid cancer	0.000564	0.000611	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—thyroid cancer	0.000564	0.000611	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—thyroid cancer	0.00056	0.000607	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—thyroid cancer	0.000557	0.000603	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—thyroid cancer	0.000554	0.0006	CcSEcCtD
Tiagabine—Cough—Epirubicin—thyroid cancer	0.00055	0.000595	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—thyroid cancer	0.000544	0.000589	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000541	0.000586	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—thyroid cancer	0.000539	0.000583	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—thyroid cancer	0.000536	0.000581	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—thyroid cancer	0.000536	0.000581	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—thyroid cancer	0.000536	0.000581	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—thyroid cancer	0.000536	0.00058	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—thyroid cancer	0.000534	0.000579	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—thyroid cancer	0.00053	0.000574	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—thyroid cancer	0.000526	0.000569	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—thyroid cancer	0.000524	0.000568	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—thyroid cancer	0.000524	0.000567	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—thyroid cancer	0.000523	0.000566	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—thyroid cancer	0.000522	0.000565	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—thyroid cancer	0.000518	0.000561	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—thyroid cancer	0.000515	0.000558	CcSEcCtD
Tiagabine—Oedema—Epirubicin—thyroid cancer	0.000514	0.000557	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000512	0.000555	CcSEcCtD
Tiagabine—Infection—Epirubicin—thyroid cancer	0.000511	0.000553	CcSEcCtD
Tiagabine—Cough—Doxorubicin—thyroid cancer	0.000509	0.000551	CcSEcCtD
Tiagabine—Shock—Epirubicin—thyroid cancer	0.000506	0.000548	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000503	0.000545	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—thyroid cancer	0.000503	0.000545	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—thyroid cancer	0.000502	0.000543	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000497	0.000538	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—thyroid cancer	0.000496	0.000537	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—thyroid cancer	0.000496	0.000537	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—thyroid cancer	0.000496	0.000537	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—thyroid cancer	0.000494	0.000535	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—thyroid cancer	0.00049	0.000531	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—thyroid cancer	0.00049	0.000531	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—thyroid cancer	0.000485	0.000526	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—thyroid cancer	0.00048	0.00052	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—thyroid cancer	0.00048	0.000519	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—thyroid cancer	0.000476	0.000515	CcSEcCtD
Tiagabine—Infection—Doxorubicin—thyroid cancer	0.000472	0.000512	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000468	0.000507	CcSEcCtD
Tiagabine—Shock—Doxorubicin—thyroid cancer	0.000468	0.000507	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000466	0.000504	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—thyroid cancer	0.000465	0.000504	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—thyroid cancer	0.000464	0.000503	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—thyroid cancer	0.000462	0.0005	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00046	0.000498	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—thyroid cancer	0.000458	0.000496	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—thyroid cancer	0.000457	0.000495	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—thyroid cancer	0.000453	0.000491	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—thyroid cancer	0.000452	0.00049	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—thyroid cancer	0.000447	0.000484	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—thyroid cancer	0.000444	0.000481	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—thyroid cancer	0.000443	0.00048	CcSEcCtD
Tiagabine—Pain—Epirubicin—thyroid cancer	0.00044	0.000476	CcSEcCtD
Tiagabine—Constipation—Epirubicin—thyroid cancer	0.00044	0.000476	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000433	0.000469	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—thyroid cancer	0.00043	0.000466	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—thyroid cancer	0.000427	0.000463	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—thyroid cancer	0.000424	0.000459	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—thyroid cancer	0.000424	0.000459	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—thyroid cancer	0.000423	0.000458	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00042	0.000455	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—thyroid cancer	0.000419	0.000453	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—thyroid cancer	0.000413	0.000448	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—thyroid cancer	0.00041	0.000444	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—thyroid cancer	0.000408	0.000442	CcSEcCtD
Tiagabine—Pain—Doxorubicin—thyroid cancer	0.000407	0.000441	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—thyroid cancer	0.000407	0.000441	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—thyroid cancer	0.000406	0.00044	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—thyroid cancer	0.000406	0.00044	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000392	0.000424	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000389	0.000421	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—thyroid cancer	0.000379	0.00041	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—thyroid cancer	0.000378	0.000409	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—thyroid cancer	0.000376	0.000407	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—thyroid cancer	0.000376	0.000407	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—thyroid cancer	0.000369	0.000399	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—thyroid cancer	0.000364	0.000394	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—thyroid cancer	0.000352	0.000381	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00035	0.00038	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—thyroid cancer	0.000341	0.00037	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—thyroid cancer	0.00034	0.000368	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—thyroid cancer	0.000336	0.000364	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—thyroid cancer	0.000327	0.000354	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—thyroid cancer	0.000325	0.000352	CcSEcCtD
Tiagabine—Rash—Epirubicin—thyroid cancer	0.000324	0.000351	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—thyroid cancer	0.000324	0.000351	CcSEcCtD
Tiagabine—Headache—Epirubicin—thyroid cancer	0.000322	0.000349	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—thyroid cancer	0.000315	0.000341	CcSEcCtD
Tiagabine—Nausea—Epirubicin—thyroid cancer	0.000305	0.000331	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—thyroid cancer	0.000302	0.000328	CcSEcCtD
Tiagabine—Rash—Doxorubicin—thyroid cancer	0.0003	0.000325	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—thyroid cancer	0.0003	0.000324	CcSEcCtD
Tiagabine—Headache—Doxorubicin—thyroid cancer	0.000298	0.000323	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—thyroid cancer	0.000283	0.000306	CcSEcCtD
